Advances in quantitative magnetic resonance imaging-based biomarkers for Alzheimer disease

Alzheimer's Research and Therapy

Volumn 2, Issue 4, 2010, Pages

  Dickerson, Bradford C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE;

ALZHEIMER DISEASE; ATROPHY; BRAIN REGION; HUMAN; MACHINE LEARNING; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATTERN RECOGNITION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY;

EID: 80052758005     PISSN: None     EISSN: 17589193     Source Type: Journal    
DOI: 10.1186/alzrt45     Document Type: Review

References (19)

1. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN, Arch Neurol 2000 57 339 344 10.1001/archneur.57.3.339 10714659 (Pubitemid 30140520)
2. MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD. Jack CR Jr, Slomkowski M, Gracon S, Hoover TM, Felmlee JP, Stewart K, Xu Y, Shiung M, O'Brien PC, Cha R, Knopman D, Petersen RC, Neurology 2003 60 253 260 10.1001/archneur.60.2.253 12552040 (Pubitemid 36193971)
3. Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Holland D, Brewer JB, Hagler DJ, Fenema-Notestine C, Dale AM, the Alzheimer's Disease Neuroimaging Initiative, Weiner M, Thal L, Petersen R, Jack CR Jr, Jagust W, Trojanowki J, Toga AW, Beckett L, Green RC, Gamst A, Potter WZ, Montine T, Anders D, Bernstein M, Felmlee J, Fox N, Thompson P, Schuff N, Alexander G, Bandy D, Koeppe RA, Foster N, Reiman EM, Chen K, et al. Proc Natl Acad Sci USA 2009 106 20954 20959 10.1073/pnas.0906053106 19996185
4. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Desikan RS, Ségonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ, Neuroimage 2006 31 968 980 10.1016/j.neuroimage.2006.01.021 16530430 (Pubitemid 44183792)
5. The cortical signature of prodromal AD: regional thinning predicts mild AD dementia. Bakkour A, Morris JC, Dickerson BC, Neurology 2009 72 1048 1055 10.1212/01.wnl.0000340981.97664.2f 19109536
6. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloidpositive individuals. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL, Cereb Cortex 2009 19 497 510 10.1093/cercor/bhn113 18632739
7. Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative. Chen K, Langbaum JB, Fleisher AS, Ayutyanont N, Reschke C, Lee W, Liu X, Bandy D, Alexander GE, Thompson PM, Foster NL, Harvey DJ, de Leon MJ, Koeppe RA, Jagust WJ, Weiner MW, Reiman EM, Alzheimer's Disease Neuroimaging Initiative, Neuroimage 2010 51 654 64 10.1016/j.neuroimage.2010.02. 064 20202480
8. Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. Hua X, Lee S, Hibar DP, Yanovsky I, Leow AD, Toga AW, Jack CR Jr, Bernstein MA, Reiman EM, Harvey DJ, Kornak J, Schuff N, Alexander GE, Weiner MW, Thompson PM, Alzheimer's Disease Neuroimaging Initiative, Neuroimage 2010 51 63 75 10.1016/j.neuroimage.2010.01.104 20139010
9. von Economo C, Cellular Structure of the Human Cerebral Cortex Basel: S. Karger AG 2009
10. Increasing loss of brain tissue with increasing dementia: a stereological study of post-mortem brains from elderly females. Regeur L, Eur J Neurol 2000 7 47 54 10.1046/j.1468-1331.2000.00017.x 10809914 (Pubitemid 32268735)
11. Distribution of cerebral degeneration in Alzheimer's disease. A clinico-pathological study. Brun A, Gustafson L, Arch Psychiatr Nervenkr 1976 223 15 33 10.1007/BF00367450 828039 (Pubitemid 8000887)
12. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Fischl B, Dale AM, Proc Natl Acad Sci USA 2000 97 11050 11055 10.1073/pnas.200033797 10984517
13. Measurement of cortical thickness using an automated 3-D algorithm: a validation study. Kabani N, Le Goualher G, MacDonald D, Evans AC, Neuroimage 2001 13 375 380 10.1006/nimg.2000.0652 11162277 (Pubitemid 34185024)
14. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Thompson PM, Mega MS, Woods RP, Zoumalan CI, Lindshield CJ, Blanton RE, Moussai J, Holmes CJ, Cummings JL, Toga AW, Cereb Cortex 2001 11 1 16 10.1093/cercor/11.1.1 11113031 (Pubitemid 32064172)
15. Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area. Dickerson BC, Feczko E, Augustinack JC, Pacheco J, Morris JC, Fischl B, Buckner RL, Neurobiol Aging 2009 30 432 440 10.1016/j.neurobiolaging.2007.07.022 17869384
16. Alzheimer's disease diagnosis in individual subjects using structural MR images: validation studies. Vemuri P, Gunter JL, Senjem ML, Whitwell JL, Kantarci K, Knopman DS, Boeve BF, Petersen RC, Jack CR Jr, Neuroimage 2008 39 1186 1197 10.1016/j.neuroimage.2007.09.073 18054253
17. Automated MRI-based classification of primary progressive aphasia variants. Wilson SM, Ogar JM, Laluz V, Growdon M, Jang J, Glenn S, Miller BL, Weiner MW, Gorno-Tempini ML, Neuroimage 2009 47 1558 1567 10.1016/j.neuroimage. 2009.05.085 19501654
18. Individual patient diagnosis of AD and FTD via high-dimensional pattern classification of MRI. Davatzikos C, Resnick SM, Wu X, Parmpi P, Clark CM, Neuroimage 2008 41 1220 1227 10.1016/j.neuroimage.2008.03.050 18474436
19. Alzheimer's disease therapeutic research: the path forward. Aisen PS, Alzheimers Res Ther 2009 1 2 10.1186/alzrt2 19674435